Come up with a name for your new list and we'll add to it:
PhaseBio Pharmaceuticals raised a round of funding on November 29, 2017. Investors include
Silicon Valley Bank.
PhaseBio Pharmaceuticals is a clinical-stage biopharmaceutical company developing drugs to treat diabetes and cardiovascular dysfunction in patients suffering from rare diseases. The Company's discove…